Abstract:Objectives: The interaction between the components of traditional Chinese medicine (TCM) is an important basis for their synergy. Rhein and curcumin exert various pharmacological activities, including anti-tumour, anti-inflammatory, antioxidant, anti-fibrosis and renoprotective effects. However, no investigation has reported the synergistic anti-fibrosis effect yet. This study aims at determine the pharmacokinetics and pharmacodynamics of the combination of rhein and curcumin in the treatment for chronic kidney disease in rats. Design: Fifty two male Sprague-Dawley (SD) rats were randomly divided into rhein group, curcumin group and their combination group for pharmacodynamics studies. HE and Masson staining was conducted to observe the changes of renal morphology. Kits were used to detect the level of urea nitrogen (BUN) and creatinine (Scr). For pharmacokinetic study, 36 SD rats were randomly divided into rhein group, curcumin group and a combination group, the content of rhein and curcumin in plasma and renal tissue was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). In additon, molecular docking method and cell experiments was used to disclose the interaction mechanism between curcumin and rhein. Results: The pharmacodynamic results showed that the degree of renal fibrosis was improved obviously by co-administration rhein and curcumin. Meanwhile, compared to single administration, the Cmax and AUC of rhein and curcumin in plasma and renal tissue were enhanced significantly after co-administration. Moreover, the result of molecular docking and cell experiments showed that both two compounds could interact with P-gp, CYP2C9 and CYP2C19. Conclusion: Together, these findings demonstrated that rhein and curcumin had a synergistic effect in ameliorateing chonic kidney disease, providing an important explanation on the synergistic mechanism of curcumin and rhein from a pharmacokinetic viewpoint.

A research update on the therapeutic potential of rhein and its derivatives

Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives

Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein

Rhein: A Review of Pharmacological Activities

Rhein: An Updated Review Concerning Its Biological Activity, Pharmacokinetics, Structure Optimization, and Future Pharmaceutical Applications

A Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone Ingredient

Advance of Biological Activity of Rhein and Its Derivatives

Updated Pharmaceutical Progress on Plant Antibiotic Rhein and Its Analogs:Bioactivities, Structure–activity Relationships and Future Perspectives

Rhein Derivatives, A Promising Pivot?

Synthesis, Screening and Nanocrystals Preparation of Rhein Amide Derivatives.

Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties

Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets

Anti-Hyperuricemic and Nephroprotective Effects of Rhein in Hyperuricemic Mice

Rhein for treating diabetes mellitus: A pharmacological and mechanistic overview

Pharmacokinetics and Pharmacodynamics of the Combination of Rhein and Curcumin in the Treatment of Chronic Kidney Disease in Rats

Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-κB signal pathways

The influence of rhein on the absorption of rehmaionoside D: In vivo, in situ, in vitro, and in silico studies

The phytochemistry and pharmacology of three Rheum species: A comprehensive review with future perspectives

Design, synthesis, and characterization of rhein analogs as novel inhibitors of scavenger receptor A

The Molecular Mechanism of Rhein in Diabetic Nephropathy

Rhein inhibits ATP-triggered inflammatory responses in rheumatoid rat fibroblast-like synoviocytes